J. Goldman & CO LP Tilray Brands, Inc. Call Options Transaction History

J. Goldman & CO LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$2.7 - $4.3 $1.82 Million - $2.9 Million	675,000 New	675,000 $1.86 Million
Q2 2022 Aug 15, 2022	SELL	$3.11 - $7.48 $583,125 - $1.4 Million	-187,500 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.88 - $8.56 $915,000 - $1.61 Million	187,500 New	187,500 $1.46 Million
Q1 2021 May 17, 2021	SELL	$9.0 - $63.91 $749,700 - $5.32 Million	-83,300 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.82 - $10.1 $401,506 - $841,330	83,300 New	83,300 $688,000
Q3 2020 Nov 16, 2020	SELL	$4.7 - $8.7 $1.59 Million - $2.93 Million	-337,300 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$5.54 - $10.81 $1.87 Million - $3.65 Million	337,300 New	337,300 $2.4 Million

405

99.8M

8.6M

8.9M

Ticker TLRY
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 611,401,984
Market Cap $905M
Description
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.